共 50 条
- [31] Bioavailability consideration in drug design. [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U459 - U459
- [32] TURN AND HELIX MIMETICS FOR PEPTIDE DESIGN. [J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1996, 52 : C559 - C559
- [37] Use of genomic information in drug design. [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U390 - U390
- [38] Integrated approaches for peptidomimetic drug design. [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : B200 - B201
- [39] Metalloamindglycosides: An inorganic approach to drug design. [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : U109 - U109
- [40] Dynamic force spectroscopy for drug design. [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U406 - U406